Education
About Us
Working with TipRanks
Follow Us
Elicera Therapeutics AB (DE:8E8)
FRANKFURT:8E8
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 0.00 | kr 7.13M | kr 11.23M | kr 1.28M | kr 587.00 |
| Gross Profit | kr 0.00 | kr 7.13M | kr 11.22M | kr 1.28M | kr -11.19K |
| Operating Income | kr -17.94M | kr -16.88M | kr -28.33M | kr -19.36M | kr -13.12M |
| EBITDA | kr -17.40M | kr -16.82M | kr -17.09M | kr -19.43M | kr -13.11M |
| Net Income | kr -17.41M | kr -16.11M | kr -16.40M | kr -19.52M | kr -13.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 24.85M | kr 26.40M | kr 29.38M | kr 43.82M | kr 52.39M |
| Total Assets | kr 27.42M | kr 27.56M | kr 30.18M | kr 46.31M | kr 54.74M |
| Total Debt | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| Net Debt | kr -24.85M | kr -26.40M | kr -29.38M | kr -43.82M | kr -52.39M |
| Total Liabilities | kr 4.06M | kr 6.79M | kr 13.78M | kr 13.51M | kr 2.50M |
| Stockholders' Equity | kr 23.36M | kr 20.77M | kr 16.40M | kr 32.80M | kr 52.24M |
| Cash Flow | |||||
| Free Cash Flow | kr -21.55M | kr -23.46M | kr -14.92M | kr -8.57M | kr -14.29M |
| Operating Cash Flow | kr -21.55M | kr -23.46M | kr -14.92M | kr -8.57M | kr -14.29M |
| Investing Cash Flow | kr 1.00K | kr 0.00 | kr 483.17K | kr 0.00 | kr -1.00K |
| Financing Cash Flow | kr 20.00M | kr 20.48M | kr 0.00 | kr 0.00 | kr 55.12M |